Perry James Arthur Files Form 3 as CFO of OPAY Ltd
Perry James Arthur has filed a Form 3 as CFO of OPAY Ltd, reflecting his role in the company and its operations in depository banking.
Wen Stephen Files Form 3, Reports Significant Stake in OPAY Ltd
Wen Stephen's recent Form 3 filing reveals his ownership stake in OPAY Ltd, where he serves as Co-CEO and COO, impacting the depository banking sector.
Riiber Knudsen Trond Reports Share Ownership in OPAY Ltd
Riiber Knudsen Trond files Form 3, detailing share ownership in OPAY Ltd, underscoring the importance of transparency in the banking sector.
Boilesen Lars Rahbaek Files Form 3 for OPAY Ltd Ownership
Boilesen Lars Rahbaek files a Form 3 detailing ownership in OPAY Ltd, showcasing compliance and transparency in the financial sector.
Wong Brian Alan-Mingway files Form 3 as OPAY Ltd director
Wong Brian Alan-Mingway files Form 3, revealing his director status at OPAY Ltd, emphasizing transparency and governance in the financial sector.
Liu Ming Hui Reports Major Stock Transactions for EnerSyn
Liu Ming Hui discloses significant stock transactions involving EnerSyn Global Inc., reflecting strategic ownership changes in the wholesale-drugs sector.
Lichty Paul Robert Files Schedule 13D for Forge Nano Holdings
Lichty Paul Robert reveals 7.5% ownership in Forge Nano Holdings, following its merger, indicating potential strategic influence within the company.
Fivespan Partners GP reports stock acquisition by Haggart
Dylan G. Haggart of Fivespan Partners GP increases his stake in Stride, Inc., signaling confidence in the educational services sector.
FOXO Technologies to Acquire Controlling Interest in Ludwig
FOXO Technologies plans to acquire a controlling stake in Ludwig Enterprises, signaling potential shifts in the medical laboratory services industry.
Aspen Neuroscience reports key ownership changes post-IPO
Aspen Neuroscience reveals significant ownership changes after its IPO, with OrbiMed Advisors and OrbiMed Capital acquiring major stakes.
Aspen Neuroscience's Boerneke Reports Stock Option Grant
Jeffrey Lee Boerneke of Aspen Neuroscience has reported a stock option grant, emphasizing the company's strategy to retain key talent in the competitive pharmaceutical industry.
Kim Vyacheslav Reports Multiple Share Transactions for Kaspi.kz
Kim Vyacheslav disclosed several transactions involving shares of Joint Stock Co Kaspi.kz, reflecting active trading by a significant shareholder.
Alpha Modus Holdings Reports Significant Shareholding Change
Alpha Modus Holdings, Inc. reveals major shareholding changes in recent SEC filing, indicating shifts in ownership dynamics within the patent leasing industry.
Matson CEO Matthew J. Cox Reports Stock Sales in SEC Filing
Matthew J. Cox, CEO of Matson, Inc., sold shares on October 29, 2026, as reported in a recent SEC filing, raising questions about future company strategies.
Aspen Neuroscience reports key ownership changes in filing
Aspen Neuroscience's recent SEC filing highlights ownership changes that could impact its market position in the pharmaceutical sector.
Aspen Neuroscience sees key ownership changes in SEC filing
Aspen Neuroscience, Inc. reveals significant ownership changes in its latest SEC filing, indicating increased investor confidence in the pharmaceutical sector.
Aspen Neuroscience reports ownership changes in SEC filing
Aspen Neuroscience, Inc. discloses ownership changes by Executive Chair Hasnain Faheem, highlighting the company's developments in pharmaceutical preparations.
Aspen Neuroscience reports new ownership changes in SEC filing
Aspen Neuroscience reveals new ownership changes, enhancing director Daniel Thomas O's stake in the company, indicating growth in the pharmaceutical sector.
HealthStream Executive Trisha Coady Reports Stock Transactions
Trisha L. Coady of HealthStream Inc reports stock transactions in an SEC filing, reflecting ongoing confidence in the company's future.
Aspen Neuroscience reveals new ownership details in filing
Aspen Neuroscience, Inc. has disclosed new ownership details in its latest SEC filing, highlighting growth in the pharmaceutical preparations sector.